Associations of serum cotinine with asthma risk in US children: a mediation analysis of body mass index
View abstract on PubMed
Summary
This summary is machine-generated.Elevated serum cotinine, a biomarker for tobacco exposure, significantly increases childhood asthma risk. Body mass index (BMI) partially mediates this association, highlighting a critical link between environmental factors and pediatric respiratory health.
Area Of Science
- Environmental Health
- Pediatric Pulmonology
- Biomarkers
Background
- Childhood asthma prevalence is rising, with tobacco smoke exposure as a key factor.
- The precise impact of tobacco exposure on pediatric asthma requires further investigation.
- Serum cotinine serves as a reliable biomarker for tobacco exposure.
Purpose Of The Study
- To investigate the association between serum cotinine levels and childhood asthma risk.
- To determine if body mass index (BMI) mediates the relationship between tobacco exposure and asthma.
- To analyze data from the National Health and Nutrition Examination Survey (NHANES) for children aged 3-12 years.
Main Methods
- Utilized NHANES data (2011-2018) including serum cotinine, physician-diagnosed asthma, and BMI.
- Employed weighted multivariable logistic regression, subgroup analyses, and smooth curve fitting.
- Conducted threshold effect and mediation analyses to explore the relationship.
Main Results
- A nonlinear relationship was observed between serum cotinine and asthma risk.
- Asthma risk saturation occurred at a Log2-serum cotinine value of -0.3 (0.81 ng/mL).
- Body mass index (BMI) accounted for approximately 12.21% of the mediating effect between cotinine and asthma risk.
Conclusions
- Elevated serum cotinine is significantly linked to increased childhood asthma risk.
- Body mass index (BMI) plays a significant mediating role in this association.
- This study underscores the importance of tobacco exposure biomarkers and BMI in pediatric asthma.
Related Concept Videos
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Initiation of Airway Inflammation:
...
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
Physical...
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Intermittent Asthma:
Symptoms occur fewer than twice a week.
Night-time awakenings due to asthma occur fewer than twice a...
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
5-Lipoxygenase Inhibitors: Some drugs in this class, like zileuton (Zyflo), inhibit an enzyme called 5-lipoxygenase. This enzyme is crucial in synthesizing...

